156 related articles for article (PubMed ID: 31659640)
21. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
22. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
23. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
24. AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer.
Nakamura S; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Yamada S; Nakayama G; Omae K; Koike M; Kodera Y
Anticancer Res; 2020 Dec; 40(12):6713-6721. PubMed ID: 33288564
[TBL] [Abstract][Full Text] [Related]
25. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
[TBL] [Abstract][Full Text] [Related]
26. Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.
Kanda M; Nomoto S; Oya H; Shimizu D; Takami H; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
J Exp Clin Cancer Res; 2014 Aug; 33(1):66. PubMed ID: 25096402
[TBL] [Abstract][Full Text] [Related]
27. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.
Yi X; Luk JM; Lee NP; Peng J; Leng X; Guan XY; Lau GK; Beretta L; Fan ST
Mol Cell Proteomics; 2008 Feb; 7(2):315-25. PubMed ID: 17934217
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
29. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
[TBL] [Abstract][Full Text] [Related]
30. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer.
Kanda M; Tanaka C; Kobayashi D; Tanaka H; Shimizu D; Shibata M; Takami H; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Nakayama G; Fujiwara M; Kodera Y
Int J Cancer; 2016 Nov; 139(10):2290-8. PubMed ID: 27459504
[TBL] [Abstract][Full Text] [Related]
32. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
[TBL] [Abstract][Full Text] [Related]
33. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
[TBL] [Abstract][Full Text] [Related]
34. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
35. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
36. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
[TBL] [Abstract][Full Text] [Related]
37. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
38. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
Kanda M; Tanaka H; Shimizu D; Miwa T; Umeda S; Tanaka C; Kobayashi D; Hattori N; Suenaga M; Hayashi M; Iwata N; Yamada S; Fujiwara M; Kodera Y
Oncogene; 2018 Sep; 37(39):5355-5366. PubMed ID: 29858600
[TBL] [Abstract][Full Text] [Related]
39. Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy.
Tanaka H; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
J Gastroenterol; 2022 Sep; 57(9):640-653. PubMed ID: 35726075
[TBL] [Abstract][Full Text] [Related]
40. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
